NPC1L1 and metabolic dysfunction-associated steatotic liver disease: Niemann-Pick C1-like 1 (NPC1L1), a key transporter mediating intestinal cholesterol absorption, has emerged as a critical therapeutic target for metabolic disorders, including NAFLD [12,13,14,15,16,17].